Patents by Inventor David Alleva

David Alleva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF TYPE 1 DIABETES
    Publication number: 20240016905
    Abstract: Methods of reversing hyperglycemia and suppressing diabetes onset in a patient at risk of developing type 1 diabetes are provided. In particular, a vector system comprising a first expression cassette encoding BCL2 associated X apoptosis regulator (BAX) and a hypermethylated second expression cassette encoding a secreted glutamic acid decarboxylase 65 (sGAD55) are administered to the patient to induce a tolerogenic response.
    Type: Application
    Filed: March 3, 2021
    Publication date: January 18, 2024
    Inventors: Shahrokh SHABAHANG, David ALLEVA, Avnesh S. THAKOR
  • METABOLIC OIL COMPOSITION, SYSTEM AND METHOD OF USE
    Publication number: 20150342210
    Abstract: An oil composition product for use in providing improvement in the metabolic function of an individual. The oil composition product, system and method provides an oil blend with improved metabolic function to an individual's diet, a system and method monitoring of the individuals food intake with the food diary, and measuring the individuals metabolism with a metabolic analyzer integrated in the system. Changes in the individuals body composition are realized as the blend of oil composition product has the ability to increase a person's ability to burn more of their daily calories as fat, thereby increasing body fat loss and preserving lean muscle tissue, weight reduction and performance when part of a sensible diet and workout plan.
    Type: Application
    Filed: June 2, 2015
    Publication date: December 3, 2015
    Applicant: THE BODY LAB, LLC
    Inventor: David ALLEVA
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20110038859
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: April 9, 2010
    Publication date: February 17, 2011
    Applicant: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer, David Alleva
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20100303807
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: February 23, 2010
    Publication date: December 2, 2010
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer, David Alleva
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20080292640
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: December 20, 2007
    Publication date: November 27, 2008
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer, David Alleva